Your institution may have access to this item. Find your institution then sign in to continue.
Title
Modified-release oral opioids: suspension of marketing authorization.
Abstract
The article reports on the European Medicines Agency's 2010 finalization of a review of modified release oral opioids of the World Health Organization level III scale for the management of pain, which concluded that the benefits of most of these medicines continue to outweigh their risks.